Biotech · Private company
Autobahn Therapeutics, Inc.
Track this companyFree. Adds Autobahn Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- ABX-002Phase 2 · Bipolar Disorder DepressionClinicalTrials.gov · fetched Nov 12, 2026
- ABX-002Phase 2 · Major Depressive DisorderClinicalTrials.gov · fetched Nov 12, 2026
- ABX-002Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolar Disorder in AdultsPHASE2 · ACTIVE_NOT_RECRUITING · started Mar 28, 2025ClinicalTrials.gov NCT06869187 · fetched Nov 12, 2026
- ABX-002 Bioequivalence and Effect of Food Study in Healthy Adult ParticipantsPHASE1 · COMPLETED · started Jan 2, 2025ClinicalTrials.gov NCT07652697 · fetched Nov 12, 2026
- Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)PHASE2 · RECRUITING · started Sep 20, 2024ClinicalTrials.gov NCT06633016 · fetched Nov 12, 2026